title: Mangostin inhibits the oxidative modification of human low density lipoprotein.
abstract: The oxidation of low density lipoprotein (LDL) may play an important role in atherosclerosis. We investigated the possible antioxidant effects of mangostin, isolated from Garcinia mangostana, on metal ion dependent (Cu2+) and independent (aqueous peroxyl radicals) oxidation of human LDL. Mangostin prolonged the lagtime to both metal ion dependent and independent oxidation of LDL in a dose dependent manner over 5 to 50 microM as monitored by the formation of conjugated dienes at 234 nm (P < 0.001). There was no significant effect of mangostin on the rate at which conjugated dienes were formed in the uninhibited phase of oxidation. Levels of thiobarbituric reactive substances (TBARS) generated in LDL were measured 4 and 24 hours after oxidation with 5 microM Cu2+ in the presence or absence of 50 microM or 100 microM mangostin. We observed an inhibition of TBARS formation with 100 microM mangostin at 4 hours (P = 0.027) but not at 24 hours (P = 0.163). Similar results were observed in the presence of 50 microM mangostin. Mangostin, at 100 microM, retarded the relative electrophoretic mobility of LDL at both 4 and 24 hours after Cu2+ induced oxidation. Mangostin (100 microM) significantly inhibited the consumption of alpha-tocopherol in the LDL during Cu2+ initiated oxidation over a 75 minute period (P < 0.001). From these results, we conclude that mangostin is acting as a free radical scavenger to protect the LDL from oxidative damage in this in vitro system.
authors.affiliation: University of Western Australia, Department of Medicine, Royal Perth Hospital, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Williams
authors.forename: M
authors.initials: M
authors.lastname: Ongsakul
authors.forename: J
authors.initials: J
authors.lastname: Proudfoot
authors.forename: K
authors.initials: K
authors.lastname: Croft
authors.forename: L
authors.initials: L
authors.lastname: Beilin
mesh_terms: D000578:Amidines / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology*; D001055:Apolipoproteins B / Q000737:chemistry; D003300:Copper / Q000378:metabolism / Q000494:pharmacology; D004586:Electrophoresis; D016166:Free Radical Scavengers; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism*; D008239:Lysine / Q000737:chemistry; D008670:Metals / Q000378:metabolism / Q000494:pharmacology; D010084:Oxidation-Reduction; D013997:Time Factors; D014810:Vitamin E / Q000378:metabolism; D014966:Xanthenes / Q000494:pharmacology*; D044004:Xanthones
chemical_list: D000578:Amidines; D000975:Antioxidants; D001055:Apolipoproteins B; D016166:Free Radical Scavengers; D008077:Lipoproteins, LDL; D008670:Metals; D014966:Xanthenes; D044004:Xanthones; D014810:Vitamin E; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; D008239:Lysine; C021053:mangostin